HERKEL; Johannes

Patent Applications and Registrations

Patent applications and USPTO patent grants for HERKEL; Johannes.The latest application filed is for "use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same".

Company Profile

4.10.16

HERKEL; Johannes - Hamburg DE
Herkel; Johannes - Wuerzberg DE
Herkel; Johannes - Weisbaden DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Akt Phosphorylation As A Biomarker For Prognosing Neurodegenerative Diseases And Treating Same App 20210041455 - OVADIA; Eran ; et al.	2021-02-11
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions Grant 10,898,436 - Freund , et al. January 26, 2	2021-01-26
Use Of Akt Phosphorylation As A Biomarker For Prognosing Neurodegenerative Diseases And Treating Same App 20190204340 - OVADIA; Eran ; et al.	2019-07-04
Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same Grant 10,288,622 - Ovadia , et al.	2019-05-14
Nanoparticle Compositions For Generation Of Regulatory T Cells And Treatment Of Autoimmune Diseases And Other Chronic Inflammatory Conditions App 20180325821 - Freund; Barbara ; et al.	2018-11-15
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions Grant 10,004,689 - Freund , et al. June 26, 2	2018-06-26
Use Of Akt Phosphorylation As A Biomarker For Prognosing Neurodegenerative Diseases And Treating Same App 20160033529 - OVADIA; Eran ; et al.	2016-02-04
Peptide Inhibitors For Mediating Stress Responses App 20150297693 - HERKEL; Johannes ; et al.	2015-10-22
Nanoparticle Compositions For Generation Of Regulatory T Cells And Treatment Of Autoimmune Diseases And Other Chronic Inflammatory Conditions App 20140294982 - Freund; Barbara ; et al.	2014-10-02
Peptide inhibitors for mediating stress responses Grant 8,790,653 - Herkel , et al. July 29, 2	2014-07-29
Compositions Of Hsp60 Peptides And Viral Antigens For Vaccination And Diagnosis App 20140120126 - Cohen; Irun R. ; et al.	2014-05-01
Use Of Akt Phosphorylation As A Biomarker For Prognosing Neurodegenerative Diseases And Treating Same App 20140088017 - Ovadia; Eran ; et al.	2014-03-27
Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis Grant 8,652,439 - Cohen , et al. February 18, 2	2014-02-18
Peptide Inhibitors For Mediating Stress Responses App 20120171233 - Herkel; Johannes ; et al.	2012-07-05
Peptide inhibitors for mediating stress responses Grant 8,067,008 - Herkel , et al. November 29, 2	2011-11-29
Compositions Of Hsp60 Peptides And Viral Antigens For Vaccination And Diagnosis App 20110256165 - Cohen; Irun R. ; et al.	2011-10-20
Immunogenic Compositions For Induction Of Anti-tumor Immunity App 20090098116 - Cohen; Irun R. ; et al.	2009-04-16
Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis App 20080279878 - Cohen; Irun R. ; et al.	2008-11-13
Peptide Inhibitors for Mediating Stress Responses App 20080267983 - Herkel; Johannes ; et al.	2008-10-30
Immunogenic compositions for induction of anti-tumor immunity Grant 7,378,092 - Cohen , et al. May 27, 2	2008-05-27
Immunogenic compositions for induction of anti-tumor immunity Grant 7,118,744 - Cohen , et al. October 10, 2	2006-10-10
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens App 20060030524 - Cohen; Irun R. ; et al.	2006-02-09
Immunogenic compositions for induction of anti-tumor immunity App 20050208065 - Cohen, Irun R. ; et al.	2005-09-22
Immunogenic compositions for induction of anti-tumor immunity App 20020197270 - Cohen, Irun R. ; et al.	2002-12-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.